ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 106969 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 106969; 2) Community: the network communities that were significantly associated with the response to NSC 106969; 3) Molecule: the relationships between components within communities and NSC 106969; 4) MDR: the compounds that were significantly associated with the NSC 106969.

NSC Compound Enrichment Correlation
NSC 729797 5-({[4-(1,3-benzoxazol-2-yl)phenyl]amino}methylene)pyrimidin e-2,4,6(1H,3H,5H)-trione 0.0260391472224207 0.19202098
NSC 761130 (E)-6-chloro-3-((2-(4-fluorophenyl)imidazo[1,2-a]pyridin-3-yl)methylene)indolin-2-one 0.0260391472224207 0.48345941
NSC 107043 Null 0.0267520285931239 0.50275535
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0267520285931239 0.24663826
NSC 13484 Null 0.0267520285931239 0.090047546
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0267520285931239 0.13264061
NSC 168516 Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- 0.0267520285931239 0.37548274
NSC 295499 Camptothecin Derivative 0.0267520285931239 0.36011819
NSC 330507 Tanespimycin 0.0267520285931239 0.10081973
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0267520285931239 0.010469278
Total:95  Current:54    [First] [Prev] [Next] [Last]